Store at room temperature (20-25C) before opening, and refrigerate (2-8C) after opening/reconstitution
Heres what the clinical evidence shows: Study Scope: 900+ participants across 6 randomized, double-blind, placebo-controlled trials Safety Profile: Indistinguishable from placebo in tolerability assessments Serious Events: Zero serious adverse events attributed to AOD-9604 Withdrawals: No treatment-related discontinuations in any trial Common Effects: Mild headache and minor GI symptoms at rates similar to placebo IGF-1 Impact: No effect on insulin-like growth factor-1 levels Metabolic Safety: No negative impact on glucose metabolism or insulin sensitivity Immunogenicity: Zero participants developed anti-AOD9604 antibodies The following analysis provides complete details on the clinical trial evidence supporting AOD-9604s favorable safety profile
Studies demonstrate oral BPC-157s ability to: Accelerate healing of gastric ulcers and intestinal anastomoses
A single peptide can influence various physiological processes, such as muscle or bone growth, healing, and/or tissue repair
The FDA convened a panel in December that could fundamentally reshape how TRT is regulated, prescribed, and accessed in America
The private prescription market for these medications in the UK is large, variable in quality, and worth navigating carefully
